Table 1 Clinicopathological characteristics of the study cohort
From: YRNA expression predicts survival in bladder cancer patients
Normal | BCA | |
|---|---|---|
n = 30 | n = 88 | |
Sex | ||
Male | 22 (73%) | 70 (79.5%) |
Female | 8 (27%) | 18 (20.5%) |
Age | ||
Mean | 66.3 | 69.1 |
Range | 43–81 | 40–91 |
Staging pT-stage | ||
pTa | n.a. | 13 (14.8%) |
pTis | n.a. | 13 (14.8%) |
pT1 | n.a. | 18 (20.5%) |
pT2 | n.a. | 12 (13.6%) |
pT3 | n.a. | 15 (17.0%) |
pT4 | n.a. | 17 (19.3%) |
Lymph node metastasis | n.a. | 23 (26.1%) |
Distant metastasis | n.a. | 2 (2.3%) |
Grading | ||
grade 1 | n.a. | 9 (10.2%) |
grade 2 | n.a. | 31 (35.2%) |
grade 3 | n.a. | 48 (54.5%) |